{"id":31564,"date":"2017-04-24T12:22:54","date_gmt":"2017-04-24T12:22:54","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=31564"},"modified":"2017-07-21T20:08:42","modified_gmt":"2017-07-21T20:08:42","slug":"24th-conference-on-retroviruses-and-opportunistic-infections-croi-2017-13-16-february-2017-seattle-2","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/31564","title":{"rendered":"24th Conference on Retroviruses and Opportunistic Infections (CROI 2017), 13-16 February 2017, Seattle"},"content":{"rendered":"<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-31226\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2017\/02\/NEW-CROI-LOGO-2017-241x300.png\" alt=\"NEW CROI LOGO 2017\" width=\"241\" height=\"300\" srcset=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2017\/02\/NEW-CROI-LOGO-2017-241x300.png 241w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2017\/02\/NEW-CROI-LOGO-2017.png 551w\" sizes=\"auto, (max-width: 241px) 100vw, 241px\" \/>This issue of HTB includes further reports from the 24th Conference on Retroviruses and Opportunistic Infections (CROI 2017) held in Seattle from 13-16 February 2017.<\/strong><\/p>\n<p>CROI is one of the leading scientific HIV meetings and the exciting news is that there was much to report.<\/p>\n<p>The conference also provides free access to the conference materials online, including comprehensive webcasts of all oral presentations, available immediately after each session.<\/p>\n<p>The programme for the meeting and abstract books can be downloaded as PDF files.<br \/>\n<a href=\"http:\/\/www.croiconference.org\/electronic-materials\">http:\/\/www.croiconference.org\/electronic-materials<\/a><\/p>\n<p>The searchable abstracts database links directly to PDF files for most posters.<br \/>\n<a href=\"http:\/\/www.croiconference.org\/abstracts\/search-abstracts\">http:\/\/www.croiconference.org\/abstracts\/search-abstracts<\/a><\/p>\n<p>New CROI reports for this issue of HTB include:<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/31471\">Dose reduction potential of nanoparticle ARV formulations confirmed in humans<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31560\">VRC01 in HIV-exposed newborns: first results support monthly injections for those at risk through breastfeeding<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31558\">Raltegravir pharmacokinetic targets met in high-risk HIV-exposed infants<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31556\">Tenofovir alafenamide exposure is modestly higher in children than adults<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31552\">New HIV diagnoses in children in UK and Ireland continue to decline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31550\">World Health Organisation paediatric dosing tool<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31540\">Pre-ART drug resistance in rural South Africa but limited clinical impact with good adherence<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31486\">Immune-based therapy canakinumab reduces inflammatory markers in HIV positive people on ART<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31476\">Significant interaction between once-weekly isoniazid\/rifapentine and daily dolutegravir: study stopped due to toxicity<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31466\">Increased risk of IRIS with integrase inhibitors reported in two studies<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31488\">Breakthrough for treating XDR-TB and ameliorating TB-IRIS<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31525\">PREP in pregnancy does not increase poor birth outcomes<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/31480\">HIV cure research and basic science: capsules from CROI 2017<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Further reports form CROI including HIV and children and advances in cure research&#8230;<\/p>\n","protected":false},"author":2,"featured_media":31431,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,236],"class_list":["post-31564","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-conference-reports","tag-conference-index","tag-croi-2017"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/31564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=31564"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/31564\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media\/31431"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=31564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=31564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=31564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}